Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,196 | -19,865 | -16,497 | -12,487 | -6,433 |
| Accounts payable and accrued liabilities | -976 | -3,408 | -1,211 | -1,536 | -1,562 |
| Other Working Capital | -1,190 | -6,869 | -4,028 | -1,963 | -2,619 |
| Other Operating Activity | 1,561 | 5,547 | 2,939 | 2,778 | 2,420 |
| Operating Cash Flow | $-3,801 | $-24,595 | $-18,796 | $-13,207 | $-8,194 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 407 | N/A | N/A | N/A |
| Common Stock Issued | 2,535 | 25,608 | 18,962 | 10,439 | 241 |
| Other Financing Activity | 9,017 | -458 | -458 | -345 | -234 |
| Financing Cash Flow | $11,553 | $25,557 | $18,503 | $10,094 | $7 |
| Beginning Cash Position | 14,439 | 13,476 | 13,476 | 13,476 | 13,476 |
| End Cash Position | 22,190 | 14,439 | 13,183 | 10,364 | 5,289 |
| Net Cash Flow | $7,751 | $963 | $-293 | $-3,113 | $-8,187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,801 | -24,595 | -18,796 | -13,207 | -8,194 |
| Free Cash Flow | -3,801 | -24,595 | -18,796 | -13,207 | -8,194 |